Low pre-existing endemic human coronavirus (HCoV-NL63)-specific T cell frequencies are associated with impaired SARS-CoV-2-specific T cell responses in people living with HIV

被引:1
|
作者
Ng'uni, Tiza L. [1 ]
Musale, Vernon [2 ,3 ]
Nkosi, Thandeka [1 ]
Mandolo, Jonathan [4 ]
Mvula, Memory [4 ]
Michelo, Clive [2 ,3 ]
Karim, Farina [1 ]
Moosa, Mohomed Yunus S. [5 ]
Khan, Khadija [1 ]
Jambo, Kondwani Charles [4 ,6 ]
Hanekom, Willem [1 ,7 ]
Sigal, Alex [1 ]
Kilembe, William [2 ,3 ]
Ndhlovu, Zaza M. [1 ,5 ,8 ,9 ]
机构
[1] Africa Hlth Res Inst AHRI, Nelson R Mandela Sch Med, Durban, South Africa
[2] Emory Univ Georgia, Ctr Excellence Influenza Res & Surveillance CEIRS, Lusaka, Zambia
[3] Ctr Family Hlth Res Zambia CFHRZ, Zambia Emory HIV Res Project ZEHRP, Lusaka, Zambia
[4] Infect & Immun Res Grp, Malawi Liverpool Wellcome Trust Clin Res Programme, Blantyre, Malawi
[5] Univ KwaZulu Natal, Sch Lab Med & Med Sci, Human Immunodeficiency Virus HIV Pathogenesis Prog, Durban, South Africa
[6] Univ Liverpool Liverpool Sch Trop Med, Dept Clin Sci, Liverpool, England
[7] UCL, Div Infect & Immun, London, England
[8] Ragon Inst Massachusetts Gen Hosp MGH, Massachusetts Inst Technol MIT, Cambridge, MA 02139 USA
[9] Harvard Univ, Cambridge, MA 02138 USA
来源
FRONTIERS IN IMMUNOLOGY | 2024年 / 14卷
基金
英国惠康基金; 美国国家卫生研究院;
关键词
HIV; SARS-CoV-2; HCoV-NL63; COVID-19; T-cell response; antibody response; ANTIBODIES;
D O I
10.3389/fimmu.2023.1291048
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background Understanding how HIV affects SARS-CoV-2 immunity is crucial for managing COVID-19 in sub-Saharan populations due to frequent coinfections. Our previous research showed that unsuppressed HIV is associated with weaker immune responses to SARS-CoV-2, but the underlying mechanisms are unclear. We investigated how pre-existing T cell immunity against an endemic human coronavirus HCoV-NL63 impacts SARS-CoV-2 T cell responses in people living with HIV (PLWH) compared to uninfected individuals, and how HIV-related T cell dysfunction influences responses to SARS-CoV-2 variants.Methods We used flow cytometry to measure T cell responses following PBMC stimulation with peptide pools representing beta, delta, wild-type, and HCoV-NL63 spike proteins. Luminex bead assay was used to measure circulating plasma chemokine and cytokine levels. ELISA and MSD V-PLEX COVID-19 Serology and ACE2 Neutralization assays were used to measure humoral responses.Results Regardless of HIV status, we found a strong positive correlation between responses to HCoV-NL63 and SARS-CoV-2. However, PLWH exhibited weaker CD4+ T cell responses to both HCoV-NL63 and SARS-CoV-2 than HIV-uninfected individuals. PLWH also had higher proportions of functionally exhausted (PD-1high) CD4+ T cells producing fewer proinflammatory cytokines (IFN gamma and TNF alpha) and had elevated plasma IL-2 and IL-12(p70) levels compared to HIV-uninfected individuals. HIV status didn't significantly affect IgG antibody levels against SARS-CoV-2 antigens or ACE2 binding inhibition activity.Conclusion Our results indicate that the decrease in SARS-CoV-2 specific T cell responses in PLWH may be attributable to reduced frequencies of pre-existing cross-reactive responses. However, HIV infection minimally affected the quality and magnitude of humoral responses, and this could explain why the risk of severe COVID-19 in PLWH is highly heterogeneous.
引用
收藏
页数:15
相关论文
共 50 条
  • [21] The pre-exposure SARS-CoV-2-specific T cell repertoire determines the quality of the immune response to vaccination
    Saggau, Carina
    Martini, Gabriela Rios
    Rosati, Elisa
    Meise, Silja
    Messner, Berith
    Kamps, Ann-Kristin
    Bekel, Nicole
    Gigla, Johannes
    Rose, Ruben
    Voss, Mathias
    Geisen, Ulf M.
    Reid, Hayley M.
    Sumbul, Melike
    Tran, Florian
    Berner, Dennis K.
    Khodamoradi, Yascha
    Vehreschild, Maria J. G. T.
    Cornely, Oliver
    Koehler, Philipp
    Krumbholz, Andi
    Fickenscher, Helmut
    Kreuzer, Oliver
    Schreiber, Claudia
    Franke, Andre
    Schreiber, Stefan
    Hoyer, Bimba
    Scheffold, Alexander
    Bacher, Petra
    IMMUNITY, 2022, 55 (10) : 1924 - +
  • [22] Spike-specific CD8+T cell responses after SARS-CoV-2 mRNA vaccination in people living with HIV
    Karl, V.
    Graeser, A.
    Kremser, A.
    Rieg, S.
    Usadel, S.
    Neumann-Haefelin, C.
    Thimme, R.
    Hofmann, M.
    Mueller, M.
    HIV MEDICINE, 2023, 24 : 305 - 305
  • [23] Evolution of protective SARS-CoV-2-specific B and T cell responses upon vaccination and Omicron breakthrough infection
    Ahmed, Mohamed I. M.
    Einhauser, Sebastian
    Peiter, Clemens
    Senninger, Antonia
    Baranov, Olga
    Eser, Tabea M.
    Huth, Manuel
    Olbrich, Laura
    Castelletti, Noemi
    Rubio-Acero, Raquel
    Carnell, George
    Heeney, Jonathan
    Kroidl, Inge
    Held, Kathrin
    Wieser, Andreas
    Janke, Christian
    Hoelscher, Michael
    Hasenauer, Jan
    Wagner, Ralf
    Geldmacher, Christof
    ISCIENCE, 2024, 27 (06)
  • [24] SARS-CoV-2-Specific T Cell Responses Are Stronger in Children With Multisystem Inflammatory Syndrome Compared to Children With Uncomplicated SARS-CoV-2 Infection
    Conway, Susan R.
    Lazarski, Christopher A.
    Field, Naomi E.
    Jensen-Wachspress, Mariah
    Lang, Haili
    Kankate, Vaishnavi
    Durkee-Shock, Jessica
    Kinoshita, Hannah
    Suslovic, William
    Webber, Kathleen
    Smith, Karen
    Cohen, Jeffrey I.
    Burbelo, Peter D.
    Zhang, Anqing
    Teach, Stephen J.
    Ibeh, Trisha
    Delaney, Meghan
    DeBiasi, Roberta L.
    Keller, Michael D.
    Bollard, Catherine M.
    FRONTIERS IN IMMUNOLOGY, 2022, 12
  • [25] SARS-CoV-2-specific T cell responses: a comparative analysis between QuantiFERON SARS-CoV-2, T-SPOT.COVID, and an in-house Omicron ELISpot
    Mak, Willem A.
    Visser, Wendy
    Koeleman, Johannes G. M.
    Ong, David S. Y.
    JOURNAL OF VIROLOGICAL METHODS, 2024, 327
  • [26] Limited boosting and long-term immunity of SARS-CoV-2-specific CD8+T cell responses after COVID-19 mRNA vaccination in people living with HIV
    Karl, Vivien
    Graeser, Anne
    Kremser, Anastasia
    Bauersfeld, Liane
    Rieg, Siegbert
    Usadel, Susanne
    Neumann-Haefelin, Christoph
    Mueller, Matthias
    Thimme, Robert
    Hofmann, Maike
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2024, 54 : 281 - 281
  • [27] SARS-CoV-2-specific T cell and humoral immunity in individuals with and without HIV in an African population: a prospective cohort study
    Ngalamika, Owen
    Lidenge, Salum J.
    Mukasine, Marie Claire
    Kawimbe, Musonda
    Kamanzi, Patrick
    Ngowi, John R.
    Mwaiselage, Julius
    Tso, For Yue
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2023, 127 : 106 - 115
  • [28] SARS-CoV-2-specific T cell responses wane profoundly in convalescent individuals 10 months after primary infection
    Li, Ziwei
    Xiang, Tiandan
    Liang, Boyun
    Liu, Jing
    Yang, Xuecheng
    Deng, Hui
    Wang, Hua
    Feng, Xuemei
    Zelinskyy, Gennadiy
    Trilling, Mirko
    Sutter, Kathrin
    Lu, Mengji
    Dittmer, Ulf
    Wang, Baoju
    Yang, Dongliang
    Zheng, Xin
    Liu, Jia
    VIROLOGICA SINICA, 2023, 38 (04) : 606 - 619
  • [29] Study of the SARS-CoV-2-specific immune T-cell responses in COVID-19-positive cancer patients
    Mansi, Laura
    Spehner, Laurie
    Daguindau, Etienne
    Bouiller, Kevin
    Almotlak, Hamadi
    Stein, Ulrich
    Bouard, Adeline
    Kim, Stefano
    Klajer, Elodie
    Jary, Marine
    Meynard, Guillaume
    Vienot, Angelique
    Nardin, Charlee
    Bazan, Fernando
    Lepiller, Quentin
    Westeel, Virginie
    Adotevi, Olivier
    Borg, Christophe
    Kroemer, Marie
    EUROPEAN JOURNAL OF CANCER, 2021, 150 : 1 - 9
  • [30] Weak SARS-CoV-2-specific responses of TIGIT-expressing CD8+ T cells in people living with HIV after a third dose of a SARS-CoV-2 inactivated vaccine
    Jin, Junyan
    Wang, Xiuwen
    Li, Yongzheng
    Yang, Xiaodong
    Wang, Hu
    Han, Xiaoxu
    Sun, Jin
    Ma, Zhenglai
    Duan, Junyi
    Zhang, Guanghui
    Huang, Tao
    Zhang, Tong
    Wu, Hao
    Zhang, Xin
    Su, Bin
    CHINESE MEDICAL JOURNAL, 2023, 136 (24) : 2938 - 2947